Bioventus (BVS) Stock Chart & Stock Price History $6.81 -0.16 (-2.30%) Closing price 04:00 PM EasternExtended Trading$6.77 -0.04 (-0.65%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Bioventus Stock Price Performance The Bioventus (BVS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 3.97%, with a year-to-date return of -35.14%. In the past month, the stock has increased 2.87%, reflecting recent market activity. As of the latest close, Bioventus traded at $6.97 with a market cap of $572.54 million and volume of 402,711 shares. Receive BVS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Bioventus and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-6.97%1 Month Performance+2.87%3 Month Performance-14.02%Year-To-Date Performance-35.14%1 Year Performance+3.97% BVS Stock Chart for Monday, July, 14, 2025 BVS Chart by TradingView Bioventus Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025$7.39$6.97-5.68%$7.32$6.87402,711 shs$572.54 million07/10/2025$7.32$7.39+0.96%$7.44$7.18296,552 shs$607.04 million07/09/2025$7.07$7.32+3.54%$7.41$6.93470,645 shs$601.29 million07/08/2025$6.82$7.07+3.67%$7.08$6.81289,326 shs$580.76 million07/07/2025$7.14$6.82-4.54%$7.23$6.81428,692 shs$560.22 million07/04/2025$7.14$7.14$7.04$6.86172,470 shs$586.84 million07/03/2025$6.85$7.14+4.29%$7.04$6.86172,470 shs$562.69 million07/02/2025$6.97$6.85-1.72%$7.02$6.82268,974 shs$562.69 million07/01/2025$6.62$6.97+5.29%$7.21$6.65426,669 shs$572.54 million06/30/2025$6.77$6.62-2.22%$6.80$6.52585,164 shs$543.79 million Get the Latest News and Ratings for BVS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bioventus and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025$6.66$6.77+1.65%$6.86$6.642.03 million shs$556.12 million06/26/2025$6.69$6.66-0.45%$6.69$6.33358,334 shs$547.08 million06/25/2025$6.76$6.69-1.04%$6.97$6.66554,256 shs$549.54 million06/24/2025$6.52$6.76+3.68%$6.79$6.50323,049 shs$555.29 million06/23/2025$6.55$6.52-0.46%$6.59$6.22350,470 shs$535.58 million06/20/2025$6.43$6.55+1.87%$6.62$6.40690,124 shs$538.04 million06/19/2025$6.43$6.43$6.56$6.32278,962 shs$528.19 million06/18/2025$6.35$6.43+1.26%$6.56$6.32278,962 shs$528.19 million06/17/2025$6.60$6.35-3.79%$6.60$6.33258,978 shs$521.61 million06/16/2025$6.62$6.60-0.30%$6.70$6.57209,232 shs$542.15 million06/13/2025$6.71$6.62-1.34%$6.78$6.54255,302 shs$543.79 million Related Companies NovoCure Stock Price Chart Enovis Stock Price Chart LeMaitre Vascular Stock Price Chart National Vision Stock Price Chart CONMED Stock Price Chart Artivion Stock Price Chart Cadre Stock Price Chart Establishment Labs Stock Price Chart Tandem Diabetes Care Stock Price Chart Paragon 28 Stock Price Chart Receive BVS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Bioventus and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:BVS) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAn extra $1,000 per month?A little-known Title 15 provision could let you collect instant payouts — $100 to $1,000 — directly from your ...TradeSmith | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioventus Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioventus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BVS Stock Alerts